News

DATA CONFIRMING PERFORMANCE OF SERA PROGNOSTIC’S PRETRM® TEST TO BE PRESENTED AT THE SOCIETY FOR MATERNAL-FETAL MEDICINE’S 40TH ANNUAL PREGNANCY MEETING

SALT LAKE CITY, January 28, 2020 — Sera Prognostics, Inc., the leading women’s precision pregnancy company, today announced two podium presentations Read more...

Conformal Medical Announces First Left Atrial Appendage Closures Performed Under Conscious Sedation with its CLAAS Technology at AF Symposium 2020

Nashua, N.H. – January 22, 2020 – Conformal Medical, Inc. announced today the presentation of the first left atrial appendage closure (LAAC) cases Read more...

SERA PROGNOSTICS ANNOUNCES COMPLETION OF IMPORTANT PREVENT PTB CLINICAL INTERVENTION STUDY USING THE PRETRM® TEST

Data quantifying the benefit of Sera’s PreTRM® strategy submitted for scientific review SALT LAKE CITY – January 9, 2020 – Sera Prognostics, Read more...

SERA PROGNOSTICS TO PRESENT AT THE 38TH ANNUAL JP MORGAN HEALTHCARE CONFERENCE

January 6, 2020 — Sera Prognostics, Inc., the leading health diagnostics company dedicated to improving the lives of women and babies through individualized Read more...

New Scientific Publication Shows Sera Prognostics Is Leader in Assessing Preterm Birth Risk

Highlights the Proper Experimental Design and Reporting Required for Accurate Biomarker Prediction Performance Sera Approach Exemplifies Best Practice Read more...

Sera Prognostics Raises $36 Million Series D Financing Led by Blue Ox Healthcare Partners

Two Strategic Healthcare Companies Join Investment Round Key Scientific Publication in Obstetrics & Gynecology Shows Sera is the Leading Authority Read more...

Conformal Medical Announces Presentation of US Feasibility Study Data at TCT 2019 in San Francisco

Nashua, NH – September 23, 2019 – Conformal Medical, Inc., developer of the Conformal Left Atrial Appendage Closure (LAAC) System, will present data Read more...

Catalyst Health Ventures Wins Healthcare Fund of the Year at the New England Venture Capital Association’s 2019 NEVY Awards

BOSTON, May 10, 2019 /PRNewswire/ -- Catalyst Health Ventures was announced as the winner for Healthcare Fund of the Year at 'The 007th Annual NEVY Read more...

Page 3 of 33« First...234...Last »

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184